A carregar...
LAG3 (CD223) as a Cancer Immunotherapy Target
Despite the impressive impact of CTLA4 and PD1-PDL1 targeted cancer immunotherapy, a large proportion of patients with many tumor types fail to respond. Consequently, the focus has shifted to targeting alternative inhibitory receptors (IRs) and suppressive mechanisms within the tumor microenvironmen...
Na minha lista:
| Publicado no: | Immunol Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338468/ https://ncbi.nlm.nih.gov/pubmed/28258692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12519 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|